ACTA1 and neoplasm: The effect of the tumour microenvironment on chemoresistance to gemcitabine (a drug used to treat PDAC) [59] has been argued from results showing a protective effect of αSMA+ stromal cells on hepatocellular carcinoma and pancreatic cancer through their association with vascularisation [60].